To reduce heart disease risk, it's the quality, not the quantity, of carbs or fats that matter, says new study from the ...

Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention ...

The rejection is the latest instance of Vinay Prasad overruling career FDA scientists to place vaccines under harsher ...

So: Moderna says it was blindsided by the FDA, and Vinay Prasad, on its mRNA flu vaccine. Meanwhile, regulators are moving ...

Even when promising clinical trials exist, and the FDA allows expanded access, rare disease patients like my granddaughter ...

The country’s second largest Medicare Advantage insurer had to dramatically scale back its offerings last year after it sold generous plans that attracted sicker-than-expected members. Going into 2026 ...

Sanofi is replacing Paul Hudson as CEO, amid questions about which medicines will drive the company's growth in the future.

In the United States and elsewhere, there’s been a major shift in patients treated for lung cancer. As the percentage of ...

A federal regulatory crackdown on Hims could impact a broader network of compounding pharmacies and telehealth companies.

Applicants to a prestigious National Science Foundation fellowship program say many submissions have been mysteriously ...

As President Trump hails pricing agreements with the pharmaceutical industry, some biotech companies are worried they have been left out in the cold.

The director-general of the WHO said a U.S.-funded study of the hepatitis B vaccine in Guinea-Bissau would be “unethical” if ...